ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Research Projects Banner

Research Projects

Deciphering the role of phosphatidylinoitol 3-kinase oncogenic mutation in conferring anti HER2 therapy resistance by enriching for the stem-like tumor initiating cell population in HER2 oncogene-positive breast cancer

Implementing Organization

Shiv Nadar Foundation, Noida
Principal Investigator
Dr. Anindia Chakrabarty
Shiv Nadar Foundation, Noida

Project Overview

The project aims to decipher the role of phosphatidylinoitol 3-kinase oncogenic mutation in conferring anti HER2 therapy resistance by enriching for the stem-like tumor initiating cell population in HER2 oncogene-positive breast cancer.

Related Research

View All
Funding Organization
Funding Organization
Department of Biotechnology (DBT)
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
HER2 oncogene-positive breast cancer
Start Year
2014
End Year
2019
Status
Completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop